Executive Summary

Oct 2019
PROSPECTS
Environmental factors increase sales growth in 2019

Cough, cold and allergy (hay fever) remedies have been on the increase over the review period and are expected to keep increasing over the forecast period. The growth has been driven by the high level of polluted air, dusty environments and too much carbon monoxide produced by industries, cars and generators which are very dangerous to health.

Decongestants continues to record high sales

Decongestants are remedies also strongly gaining ground in OTC in cough, cold and allergy (hay fever) remedies over the review, and the category is expected to record even higher sales over the forecast period because the products are easily accessible and very easy to use. Population increase drives growth as many consumers use decongestants because of their efficacy.

Increasing birth rate drives growth for paediatric cough/cold remedies

An increase in new-born babies drives growth for paediatric cough/cold remedies; the rise in the rate of childbirth is mainly due to the weak enabling environment, characterised by pervasive cultural/religious practices, gender norms, and poverty among Nigerians.

Increasing allergy rate will drive category growth

Cough, cold and allergy (hay fever) remedies is projected to record heavy sales growth as allergies are expected to increase among Nigerians over the forecast period. Pollution and urbanisation are expected to be the drivers behind the heavy sales growth in the country.

COMPETITIVE LANDSCAPE
Nigerian-German Chemicals Plc and Emzor Pharmaceutical enjoy success in 2019

Nigerian-German Chemicals Plc and Emzor Pharmaceutical have been seeing huge success and compete strongly for a leading position in cough, cold and allergy (hay fever) remedies in 2019. Nigerian-German Chemicals Plc with the brands Benylin and Broncholyte Bromehexin Hcl leads cough remedies; despite the ban on codeine, these brands have enjoyed success as they are popular in the market and enjoy high share coupled with ever increasing population and youth dominance in Nigeria.

GlaxoSmithKline Consumer Healthcare and Orange Drugs Ltd lead combination products

GlaxoSmithKline Consumer Healthcare, the leading player in cough, cold and allergy (hay fever) remedies overall, and Orange Drugs Ltd are the major players in combination products. GlaxoSmithKline Consumer Healthcare leads with its brands Actifed and Panadol Cold & Catarrh.

Procter & Gamble Nigeria Ltd continues to lead medicated confectionery

Medicated confectionery saw increased value sales in 2019 and Procter & Gamble Nigeria Ltd is expected to continue leading sales over the forecast period. Procter & Gamble Nigeria Ltd leads with its brands Vicks Lemon, and Vicks Blue which is backed by frequent advertising on media across the country and is popularly known as Baba Blue.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Cough, Cold and Allergy (Hay Fever) Remedies in Nigeria

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Nigeria with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Nigeria, our research will save you time and money while empowering you to make informed, profitable decisions.

The Cough, Cold and Allergy (Hay Fever) Remedies in Nigeria market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in Nigeria?
  • What are the major brands in Nigeria?
  • What is the impact of influenza vaccinations on the sales of cough and cold products?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Cough, Cold and Allergy (Hay Fever) Remedies in Nigeria - Category analysis

HEADLINES

PROSPECTS

Environmental factors increase sales growth in 2019
Decongestants continues to record high sales
Increasing birth rate drives growth for paediatric cough/cold remedies
Increasing allergy rate will drive category growth

COMPETITIVE LANDSCAPE

Nigerian-German Chemicals Plc and Emzor Pharmaceutical enjoy success in 2019
GlaxoSmithKline Consumer Healthcare and Orange Drugs Ltd lead combination products
Procter & Gamble Nigeria Ltd continues to lead medicated confectionery

CATEGORY DATA

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2014-2019
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2019
Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2019
Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024

Consumer Health in Nigeria - Industry Overview

EXECUTIVE SUMMARY

Increase in healthcare spending and increased local production drives consumer health
Analgesics remains largest category
In a bid for quality healthcare local manufacturers align with multinational companies
Chemists/pharmacies remains core distribution channel
Strong growth expected for consumer health over the forecast period

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format: % Value 2014-2019
Table 15 Distribution of Consumer Health by Format and Category: % Value 2019
Table 16 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventative medicine
Switches

DEFINITIONS

SOURCES

Summary 1 Research Sources